Expert Opinion on Emerging Drugs

Papers
(The H4-Index of Expert Opinion on Emerging Drugs is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs56
Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity49
Bruton’s tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis33
Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials27
Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer26
Emerging drugs for the treatment of diabetic retinopathy20
Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD)19
Emerging synthetic drugs for the treatment of liver cirrhosis15
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer15
Emerging 5-HT receptor antagonists for the treatment of Schizophrenia13
Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials13
Emerging drugs for the treatment of neuromyelitis optica13
New drugs under development for COPD13
0.019785165786743